肥胖在类风湿关节炎风险中何时发挥作用:一项在症状性风险人群中开展的大型队列研究
研究纳入四个队列共1107例类风湿关节炎(RA)风险症状性人群,比较临床疑似关节痛(CSA)起病时BMI与年龄性别匹配的一般人群,并在CSA患者中分析肥胖与2年内炎症性关节炎(IA)发展的关联。结果显示各队列CSA患者肥胖比例均高于一般人群,但CSA内肥胖与IA发展无关联(汇总HR 1.01,95%CI 0.93-1.08)。结论认为肥胖可能在RA无症状早期阶段发挥作用。
要点
- 各队列CSA患者肥胖比例均高于年龄性别匹配的一般人群
- ACPA阳性与ACPA阴性CSA患者肥胖频率均较高
- CSA患者中肥胖与2年内IA发展无关联(汇总HR 1.01,95%CI 0.93-1.08)
核心结论
- 肥胖在CSA患者中与RA发展无关联,但CSA患者BMI已高于一般人群。
- 肥胖可能在RA无症状早期阶段发挥风险作用,而非与最终导致临床关节炎的疾病过程相关。
研究设计与样本
- 研究纳入四个队列(CSA Leiden、CSA Rotterdam、SONAR和TREAT EARLIER安慰剂组)共1107例RA风险症状性人群。
- 第一目标:将基线BMI与年龄匹配/性别匹配的一般人群BMI比较,并按ACPA状态分层。
- 第二目标:在各队列内用Cox回归分析BMI与2年内IA发展的关联,并通过Meta分析汇总所有队列。
主要发现
- CSA Leiden队列肥胖比例21.9% vs 一般人群14.0%,CSA Rotterdam队列25.7% vs 14.5%,SONAR队列26.7% vs 14.5%,TREAT EARLIER安慰剂组33.3% vs 14.9%。
- ACPA阳性与ACPA阴性CSA患者肥胖频率均较高。
- CSA患者中肥胖与正常体重相比,IA发展汇总HR 1.01(95%CI 0.93至1.08)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Obesity is a known risk factor for developing rheumatoid arthritis (RA). However, it is unclear whether obesity exerts its risk effect during the asymptomatic or the symptomatic clinically suspect arthralgia (CSA) phase of risk. To improve understanding of the effect of obesity on RA development, we aimed to (1) compare body mass index (BMI) at CSA onset to BMI of the general population and (2) study within CSA patients if obesity increases the risk for progression to RA. METHODS: 1107 symptomatic persons at risk for RA from four cohorts (CSA Leiden, CSA Rotterdam, SONAR and TREAT EARLIER placebo arm) were studied. For the first aim, baseline BMI was compared with age-matched/sex-matched BMI of the general population. Patients were stratified for anticitrullinated protein antibody (ACPA) status. Regarding the second aim, the association between BMI and inflammatory arthritis (IA) development during 2 years was studied with Cox regression analysis within each cohort and via meta-analysis in all cohorts. RESULTS: CSA patients of all cohorts were more often obese than the general population (respectively 21.9% vs 14.0%, 25.7% vs 14.5%, 26.7% vs 14.5% and 33.3% vs 14.9%, in CSA Leiden, CSA Rotterdam, SONAR, TREAT EARLIER placebo arm). Both ACPA-positive and ACPA-negative CSA patients had a higher frequency of obesity. Within CSA, obesity was not associated with IA development compared to normal weight (pooled effect in meta-analysis of four cohorts HR 1.01 (95% CI 0.93 to 1.08)). CONCLUSIONS: Obesity is not associated with RA development within CSA patients but BMI has already increased in CSA compared to the general population. Obesity, therefore, presumably exerts its risk effect at an early asymptomatic phase of RA development, rather than being associated with the disease processes that ultimately result in clinical arthritis.
引用
- Dumoulin QA, Boeren AMP, Krijbolder DI, et al. When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk. RMD Open. 2024. PMID: 38216289. doi:10.1136/rmdopen-2023-003785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。